The Boston Globe Names C4 Therapeutics a Top Place to Work for 2017
CAMBRIDGE, Mass. – C4 Therapeutics (C4T) has been named one of the Top Places to Work in Massachusetts in the 10th annual employee-based
November 17, 2017
News
Menu
C4 Therapeutics Expands Management Team with Appointment of Ron Kaiser as Chief Financial Officer
CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced it has appointed Ron Kaiser as Chief Financial Officer. Ron has more than
November 14, 2017
C4 Therapeutics Appoints Michael Kim as Vice-president of Business Development
CAMBRIDGE, Mass.– C4 Therapeutics (C4T) today announced the appointment of Michael Kim, Ph.D., as Vice President of Business Development. Dr. Kim comes
August 11, 2017
C4 Therapeutics Announces the Addition of Leading Researchers in Hematology-oncology to Scientific Advisory Board
CAMBRIDGE, Mass. – C4 Therapeutics (C4T) today announced the appointment of Scott Armstrong, M.D, Ph.D., and Ross Levine, MD, to the Company’s
July 27, 2017
C4 Therapeutics and Calico Enter Strategic Partnership to Discover Novel Therapeutics Based on Targeted Protein Degradation
CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif. – C4 Therapeutics (C4T) and Calico today announced a five-year collaboration to discover, develop and commercialize therapies for treating
March 23, 2017
